You are currently viewing a new version of our website. To view the old version click .

SynBio, Volume 3, Issue 1

March 2025 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Review
  • Open Access
1,973 Views
14 Pages

3 March 2025

The carbohydrate antigen Sda is expressed on the cells and secretions of the vast majority of Caucasians. The epitope is formed by a terminal GalNAc residue β4-linked to an α3-sialylated galactose. Different carbohydrate chains N- or O-lin...

  • Article
  • Open Access
2 Citations
2,450 Views
15 Pages

5 February 2025

Enzymes play an essential role in many different industries; however, their operating conditions are limited due to the loss of enzyme activity in the presence of proteases and at temperatures significantly above physiological conditions. One way to...

  • Review
  • Open Access
3 Citations
4,925 Views
33 Pages

3 February 2025

The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial pathogenesis and developing effective therapies. T...

  • Article
  • Open Access
1,833 Views
14 Pages

27 January 2025

Synechocystis sp. PCC 6803 is a highly promising organism for the production of diverse recombinant compounds, including biofuels. However, conventional genetic engineering in Synechocystis presents challenges due to its highly polyploid genome, whic...

  • Review
  • Open Access
2 Citations
3,377 Views
13 Pages

9 January 2025

Atherosclerosis remains a major driver for cardiovascular disease (CVD), despite advancements in traditional risk factor management therapies. Recent evidence emphasizes the crucial role of the gut microbiome in the progression of atherosclerosis and...

  • Review
  • Open Access
1 Citations
5,153 Views
18 Pages

6 January 2025

Pancreatic cancer is the result of mutations in crucial genetic markers like KRAS and TP53 that make treatment challenging. This article discusses how CRISPR Cas9 technology can be combined with these markers to create treatments. CRISPR allows for t...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
SynBio - ISSN 2674-0583